Predictive biomarkers for the efficacy of PARP inhibitors in ovarian cancer: an updated systematic review.

BJC Rep · 2025 · PMC11897386 · PMID 40069561

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

While initial results did not reach statistical significance, post-veliparib treatment changes in HOXA9 methylation correlated with survival outcomes, suggesting its potential as a predictive biomarker.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.